Research Partnership and Goals
Belles with Balls NL is proud to donate all proceeds to the Ovarian Cancer Research and Education (OCRE) Fund at Memorial University. The OCRE Fund provides assistance to researchers exploring the genetic markers that may impact Ovarian Cancer patients in Newfoundland and Labrador. As well, it hosts educational events for the general public with speakers from various professions including researchers, oncologists, gynecologists, a nurse, pharmacist, psychologist and Ovarian Cancer survivors.
Currently, there is no effective detection test for Ovarian Cancer which unfortunately results in most patients being diagnosed in late stages of the disease. By supporting OCRE, Belles with Balls NL hopes to further uncover the genetic component of Ovarian Cancer to create a better detection test.
The Faculty of Medicine at Memorial University is currently researching Ovarian Cancer genetics through the Lynch Syndrome Lab. The Ovarian Cancer research team at Memorial is led by Dr. Lesa Dawson MD FRCSC and Dr. Darren O’Rielly PhD CCMG. Dr. Dawson is an Associate Professor at Memorial University and a Gynecologic Oncologist who specializes in cancer genetics and prevention. Dr. O’Rielly is the director of the molecular genetics laboratory at Memorial University.
Ovarian Cancer-specific Newfoundland-based research studies ongoing include:
The Lynch Syndrome Lab consists of a very dedicated staff of professionals including Dr. Lesa Dawson and Dr. Darren O’Rielly who along with their colleagues, work on the projects listed above. To find out more about them please see the research team.
We would like to draw attention to Dr. Lesa Dawson and Kerri Smith who work closely with the Ovarian Cancer Research and Education (OCRE) fund and dedicate countless hours to the research projects.
WE NEED YOUR PARTICIPATION! HELP MUN CONTINUE WITH RESEARCH THAT THE BELLES ARE INVOLVED WITH.
Help Multidisciplinary study team at Memorial University led by Dr. Holly Etchegary, Associate Professor of Clinical Epidemiology at the Faculty of Medicine, looking to better understand the experiences of people with hereditary cancer syndromes (individuals who had a genetic test and tested positive for any hereditary cancer gene e.g., Lynch syndrome, BRCA 1 or 2, PALB2, CHEK2, CDH1, RAD51C, MEN1, VHL, etc.), as well as what kind of support they may need to help manage their cancer risks.
A better understanding of these patients’ needs can help create supports and services for patients with hereditary cancers.
Potential participants who are interested in participating in a 45-60 minute interview over the phone, in person, or video conferencing can contact Rebecca Puddester; 709-697-2928; Email: firstname.lastname@example.org OR Tanya Burry; 709-864-6623; Email: email@example.com
This study has received funding from the Canadian Institute of Health Research and has been approved by the NL Health Research Ethics Authority.